Skip to main content
Premium Trial:

Request an Annual Quote

NHGRI Plans to Fund Pediatric eMERGE Genomics Studies

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute expects to publish an announcement this summer that will offer funding opportunities to investigators using pediatric genome-wide genotyping data to join in the second phase of the Electronic Medical Records and Genomic Research (eMERGE) Network.

NHGRI said this week that it wants researchers with expertise and insights in conducting genomic research in pediatric biorepositories with electronic medical records to begin thinking about applying for the new funding opportunity.

The aim of the initiative will be to build upon the eMERGE Network's Phase I experience in defining phenotypes from electronic medical records, conducting genome-wide association studies, reducing privacy risks, and developing community consultation procedures, and to incorporate those lessons into pediatric genomics research and clinical care.

These research areas could involve expanding the eMERGE electronic phenotyping library, expanding eMERGE sites to include children and under-represented minorities, and incorporating genome-wide association genotyping information into EMRs in order to improve genetic risk assessment, prevention, diagnosis, treatment, and accessibility of genomic medicine.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.